KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
Market Analysis
Neutral

Wall Street Raises Target Prices for Apple, Micron Amid Tech Sector Optimism

Published October 8, 2026 6:19 AM · 5 views $AAPL $NVDA $MU $MRVL
Wall Street Raises Target Prices for Apple, Micron Amid Tech Sector Optimism

As major U.S. companies prepare to report earnings, Wall Street is seeing continued optimism around key technology stocks. Buy recommendations are also emerging for financial, healthcare, and commodities sectors based on improving performance and undervaluation.

According to CNBC on July 7 (local time), Yorkville Associates initiated coverage of Apple and Nvidia with 'outperform' ratings, setting target prices at $400 for Apple and $300 for Nvidia. Apple's growth potential was cited due to ecosystem expansion, while Nvidia's competitive advantage was highlighted as the investment rationale.

In the semiconductor sector, Micron and Marvell Technology saw improved ratings. DA Davidson maintained a 'buy' rating after meeting with Micron's management, raising its target price from $2100 to $3000. TD Cowen upgraded Marvell from 'hold' to 'buy,' citing strong growth in connected technology businesses and reduced concerns over customer concentration and profitability in custom computing chips (XPU).

Overall tech sector expectations remain positive. Evercore ISI raised its rating for NetApp to 'outperform,' setting a $300 target price, while UBS maintained a 'neutral' view on Tesla with a slightly increased target range of $385-$391, noting long-term business potential may support the stock more than short-term results.

In financial stocks, growth and M&A market recovery are drawing attention. UBS cited Invesco's sustained growth as undervalued in the market, maintaining a 'buy' rating with a $41 target price. KBW raised its rating for Moelis & Company to 'outperform,' anticipating benefits from increased activity in M&A deals under $1 billion. Conversely, PJT Partners lowered its recommendation due to discrepancies between deal progress and actual closing metrics.

In healthcare, Cantor Fitzgerald upgraded Humana's earnings outlook, raising the target price from $300 to $460 and changing the rating from 'neutral' to 'overweight.' Barclays initiated coverage of Abbott Laboratories with an 'overweight' rating, citing diverse business foundations and strong product development capabilities.

Some analysts view market corrections as buying opportunities. Citigroup upgraded Flutter Entertainment's U.S. business outlook positively, raising its rating to 'buy.' XPO also received a 'buy' recommendation following share price declines, with growth in market share and improved pricing power cited as key factors.

In commodities, Morgan Stanley raised both Gold Fields and Nexa Resources to 'overweight.' Gold Fields was noted for underperformance this year creating investment opportunities, while Nexa Resources was highlighted for being undervalued relative to earnings forecasts and having high free cash flow yield.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 월가, 애플·마이크론 목표가 상향…매수 의견 확산